Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 26:23:2543-2549.
doi: 10.12659/msm.902016.

Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study

Affiliations

Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study

Yan Liang et al. Med Sci Monit. .

Abstract

BACKGROUND This study aimed to estimate the point prevalence of myositis and identify associated variables of myositis in systemic lupus erythematosus (SLE). MATERIAL AND METHODS Clinical date of patients hospitalized with lupus at the First Affiliated Hospital of Anhui Medical University and Anhui Provincial Hospital were collected. Patients were defined as having myositis if they reported the presence of persistent invalidating muscular weakness combined with increased levels of creatine phosphokinase (CPK) and abnormal electromyography (EMG). RESULTS The study sample comprised 1701 lupus patients, of which 44 had myositis. Patients with SLE-associated myositis are more likely to have skin rash, alopecia, pericarditis, vasculitis, anti-Sm, anti-RNP, anti-dsDNA, thrombocytopenia, leukopenia, low C3, low C4, high erythrocyte sedimentation rate (ESR), high D-dimer, and active disease. Multivariate logistic regression found positive associations between leukopenia, alopecia, and active disease with myositis. Negative associations between myositis with the use of corticosteroids or immunosuppressive drugs were revealed in univariate and multivariate analysis. CONCLUSIONS The point prevalence of myositis was 2.6% in SLE patients. The significant association of alopecia, leukopenia, and active disease with myositis suggests that organ damage, hematological abnormality, and high disease activity promote the progression of myositis in lupus patients.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests

None.

References

    1. Liang Y, Xu WD, Peng H, et al. SOCS signaling in autoimmune diseases: Molecular mechanisms and therapeutic implications. Eur J Immunol. 2014;44:1265–75. - PubMed
    1. Maazoun F, Frikha F, Snoussi M, et al. Systemic lupus erythematosusmyositis overlap syndrome: report of 6 cases. Clin Pract. 2011;1:e89. - PMC - PubMed
    1. Record JL, Beukelman T, Cron RQ. High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort. Pediatr Rheumatol Online J. 2011;9:20. - PMC - PubMed
    1. Dayal NA, Isenberg DA. SLE/myositis overlap: Are the manifestations of SLE different in overlapdisease? Lupus. 2002;11:293–98. - PubMed
    1. Estes D, Chlaristian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Balt) 1971;50:85–95. - PubMed